US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 8.760
  • +0.190+2.22%
Close Dec 3 16:00 ET
  • 8.750
  • -0.010-0.11%
Post 16:30 ET
185.66MMarket Cap-1598P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Total revenue
-14.61%67.64M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
-23.67%18M
-8.07%79.2M
-6.82%18.93M
-3.01%18.89M
-4.92%17.8M
-14.70%23.59M
Operating revenue
-14.61%67.64M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
-23.67%18M
-8.07%79.2M
-6.82%18.93M
-3.01%18.89M
-4.92%17.8M
-14.70%23.59M
Cost of revenue
Gross profit
Operating expense
-12.52%189.33M
-11.01%44.46M
-24.19%42.16M
-12.97%49.82M
-1.32%52.89M
3.05%216.41M
5.48%49.96M
6.89%55.61M
8.91%57.25M
-7.68%53.6M
Selling and administrative expenses
9.38%57.85M
-0.81%13.68M
6.31%13.41M
3.32%14.24M
30.10%16.52M
16.28%52.89M
9.75%13.8M
-2.41%12.62M
31.52%13.78M
33.53%12.7M
-General and administrative expense
9.38%57.85M
-0.81%13.68M
6.31%13.41M
3.32%14.24M
30.10%16.52M
16.28%52.89M
9.75%13.8M
-2.41%12.62M
31.52%13.78M
33.53%12.7M
Research and development costs
-19.60%131.48M
-14.90%30.78M
-33.14%28.74M
-18.14%35.59M
-11.08%36.37M
-0.61%163.52M
3.94%36.17M
9.97%42.99M
3.28%43.47M
-15.75%40.9M
Operating profit
11.31%-121.69M
3.79%-29.85M
34.12%-24.19M
16.95%-32.77M
-16.24%-34.89M
-10.79%-137.21M
-14.72%-31.03M
-12.82%-36.71M
-16.56%-39.45M
1.30%-30.01M
Net non-operating interest income expense
-38.35%3.83M
-60.67%595K
-39.43%1.13M
-32.17%1.25M
-13.70%857K
294.91%6.21M
139.78%1.51M
375.57%1.87M
620.39%1.84M
993K
Non-operating interest income
30.02%14.77M
-31.90%3.18M
-9.80%3.49M
107.35%3.81M
332.83%4.3M
622.19%11.36M
639.14%4.66M
883.72%3.87M
620.39%1.84M
--993K
Non-operating interest expense
112.51%10.94M
-18.09%2.58M
17.93%2.36M
--2.56M
--3.44M
--5.15M
--3.15M
--2M
--0
--0
Other net income (expense)
73K
Gain on sale of security
--73K
----
----
----
----
----
----
----
----
----
Income before tax
10.08%-117.79M
1.12%-29.19M
33.84%-23.05M
16.20%-31.52M
-17.26%-34.03M
-7.21%-131M
-12.09%-29.52M
-8.39%-34.84M
-11.97%-37.61M
3.75%-29.02M
Income tax
-161.79%-1.74M
74.26%-363K
-109.36%-395K
-925.00%-363K
-1,729.41%-622K
751.50%2.82M
-10,171.43%-1.41M
1,044.30%4.22M
44K
5.56%-34K
Net income
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
Net income continuous Operations
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
Minority interest income
Net income attributable to the parent company
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
Basic earnings per share
14.11%-5.48
-2.26%-1.36
42.47%-1.07
17.88%-1.47
-13.67%-1.58
-7.95%-6.38
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
6.08%-1.39
Diluted earnings per share
14.11%-5.48
-2.26%-1.36
42.47%-1.07
17.88%-1.47
-13.67%-1.58
-7.95%-6.38
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
6.08%-1.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Total revenue -14.61%67.64M-22.84%14.61M-4.88%17.97M-4.16%17.05M-23.67%18M-8.07%79.2M-6.82%18.93M-3.01%18.89M-4.92%17.8M-14.70%23.59M
Operating revenue -14.61%67.64M-22.84%14.61M-4.88%17.97M-4.16%17.05M-23.67%18M-8.07%79.2M-6.82%18.93M-3.01%18.89M-4.92%17.8M-14.70%23.59M
Cost of revenue
Gross profit
Operating expense -12.52%189.33M-11.01%44.46M-24.19%42.16M-12.97%49.82M-1.32%52.89M3.05%216.41M5.48%49.96M6.89%55.61M8.91%57.25M-7.68%53.6M
Selling and administrative expenses 9.38%57.85M-0.81%13.68M6.31%13.41M3.32%14.24M30.10%16.52M16.28%52.89M9.75%13.8M-2.41%12.62M31.52%13.78M33.53%12.7M
-General and administrative expense 9.38%57.85M-0.81%13.68M6.31%13.41M3.32%14.24M30.10%16.52M16.28%52.89M9.75%13.8M-2.41%12.62M31.52%13.78M33.53%12.7M
Research and development costs -19.60%131.48M-14.90%30.78M-33.14%28.74M-18.14%35.59M-11.08%36.37M-0.61%163.52M3.94%36.17M9.97%42.99M3.28%43.47M-15.75%40.9M
Operating profit 11.31%-121.69M3.79%-29.85M34.12%-24.19M16.95%-32.77M-16.24%-34.89M-10.79%-137.21M-14.72%-31.03M-12.82%-36.71M-16.56%-39.45M1.30%-30.01M
Net non-operating interest income expense -38.35%3.83M-60.67%595K-39.43%1.13M-32.17%1.25M-13.70%857K294.91%6.21M139.78%1.51M375.57%1.87M620.39%1.84M993K
Non-operating interest income 30.02%14.77M-31.90%3.18M-9.80%3.49M107.35%3.81M332.83%4.3M622.19%11.36M639.14%4.66M883.72%3.87M620.39%1.84M--993K
Non-operating interest expense 112.51%10.94M-18.09%2.58M17.93%2.36M--2.56M--3.44M--5.15M--3.15M--2M--0--0
Other net income (expense) 73K
Gain on sale of security --73K------------------------------------
Income before tax 10.08%-117.79M1.12%-29.19M33.84%-23.05M16.20%-31.52M-17.26%-34.03M-7.21%-131M-12.09%-29.52M-8.39%-34.84M-11.97%-37.61M3.75%-29.02M
Income tax -161.79%-1.74M74.26%-363K-109.36%-395K-925.00%-363K-1,729.41%-622K751.50%2.82M-10,171.43%-1.41M1,044.30%4.22M44K5.56%-34K
Net income 13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M
Net income continuous Operations 13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M
Minority interest income
Net income attributable to the parent company 13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M
Basic earnings per share 14.11%-5.48-2.26%-1.3642.47%-1.0717.88%-1.47-13.67%-1.58-7.95%-6.38-4.72%-1.33-21.57%-1.86-9.82%-1.796.08%-1.39
Diluted earnings per share 14.11%-5.48-2.26%-1.3642.47%-1.0717.88%-1.47-13.67%-1.58-7.95%-6.38-4.72%-1.33-21.57%-1.86-9.82%-1.796.08%-1.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data